X-30250539-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_177404.3(MAGEB1):​c.46C>T​(p.Arg16Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000258 in 1,203,386 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R16H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000062 ( 0 hom., 2 hem., cov: 24)
Exomes 𝑓: 0.000022 ( 0 hom. 10 hem. )

Consequence

MAGEB1
NM_177404.3 missense

Scores

1
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.121

Publications

2 publications found
Variant links:
Genes affected
MAGEB1 (HGNC:6808): (MAGE family member B1) This gene is a member of the MAGEB gene family. The members of this family have their entire coding sequences located in the last exon, and the encoded proteins show 50 to 68% sequence identity to each other. The promoters and first exons of the MAGEB genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. This gene is localized in the DSS (dosage-sensitive sex reversal) critical region, and expressed in testis and in a significant fraction of tumors of various histological types. This gene and other MAGEB members are clustered on chromosome Xp22-p21. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene, however, the full length nature of some variants has not been defined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.11675346).
BS2
High Hemizygotes in GnomAd4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGEB1NM_177404.3 linkc.46C>T p.Arg16Cys missense_variant Exon 2 of 2 ENST00000397548.4 NP_796379.1 P43366
MAGEB1NM_002363.5 linkc.46C>T p.Arg16Cys missense_variant Exon 4 of 4 NP_002354.2 P43366
MAGEB1NM_177415.3 linkc.46C>T p.Arg16Cys missense_variant Exon 3 of 3 NP_803134.1 P43366

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGEB1ENST00000397548.4 linkc.46C>T p.Arg16Cys missense_variant Exon 2 of 2 1 NM_177404.3 ENSP00000380681.2 P43366
MAGEB1ENST00000378981.8 linkc.46C>T p.Arg16Cys missense_variant Exon 4 of 4 1 ENSP00000368264.3 P43366
MAGEB1ENST00000397550.6 linkc.46C>T p.Arg16Cys missense_variant Exon 3 of 3 1 ENSP00000380683.1 P43366

Frequencies

GnomAD3 genomes
AF:
0.0000620
AC:
7
AN:
112884
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000129
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000562
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000238
AC:
4
AN:
168234
AF XY:
0.0000369
show subpopulations
Gnomad AFR exome
AF:
0.000238
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000133
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000220
AC:
24
AN:
1090502
Hom.:
0
Cov.:
31
AF XY:
0.0000280
AC XY:
10
AN XY:
356992
show subpopulations
African (AFR)
AF:
0.000191
AC:
5
AN:
26127
American (AMR)
AF:
0.00
AC:
0
AN:
34111
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18960
East Asian (EAS)
AF:
0.000133
AC:
4
AN:
30074
South Asian (SAS)
AF:
0.00
AC:
0
AN:
52342
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40289
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4088
European-Non Finnish (NFE)
AF:
0.0000167
AC:
14
AN:
838748
Other (OTH)
AF:
0.0000219
AC:
1
AN:
45763
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000620
AC:
7
AN:
112884
Hom.:
0
Cov.:
24
AF XY:
0.0000571
AC XY:
2
AN XY:
35022
show subpopulations
African (AFR)
AF:
0.000129
AC:
4
AN:
31060
American (AMR)
AF:
0.00
AC:
0
AN:
10788
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2659
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3580
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2743
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000562
AC:
3
AN:
53345
Other (OTH)
AF:
0.00
AC:
0
AN:
1526
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000110
Hom.:
0
Bravo
AF:
0.0000453
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000495
AC:
6

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 24, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.46C>T (p.R16C) alteration is located in exon 4 (coding exon 1) of the MAGEB1 gene. This alteration results from a C to T substitution at nucleotide position 46, causing the arginine (R) at amino acid position 16 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.024
T;T;T
FATHMM_MKL
Benign
0.049
N
LIST_S2
Benign
0.55
.;T;.
M_CAP
Benign
0.0040
T
MetaRNN
Benign
0.12
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.8
M;M;M
PhyloP100
0.12
PrimateAI
Benign
0.45
T
PROVEAN
Pathogenic
-6.7
D;D;D
REVEL
Benign
0.042
Sift
Uncertain
0.021
D;D;D
Sift4G
Uncertain
0.038
D;D;D
Polyphen
0.83
P;P;P
Vest4
0.15
MVP
0.61
MPC
0.25
ClinPred
0.28
T
GERP RS
0.13
Varity_R
0.23
gMVP
0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375655806; hg19: chrX-30268656; COSMIC: COSV104701669; API